Clinical Biomarkers in Gene Editing Therapy for Sickle Cell Disease

• Reviewing clinical biomarkers to support clinical endpoints
• Exploring strategies to assess disease pathophysiology and to accelerate clinical development

Speakers:

Priya S. Chockalingam

Vice President & Head, Clinical Bioanalytics & Translational Sciences

Beam Therapeutics